Bernard Fongang

University of Texas Health Science Center at San Antonio
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (3)

A growing body of evidence suggests that only a few amino acids (“hot-spots”) at the interface contribute most of the binding energy in transient protein-protein interactions. However, experimental protocols to identify these hot-spots are highly labor-intensive and expensive. Computational methods, including evolutionary couplings, have been proposed to predict the hot-spots, but they generally fail to provide details of the interacting amino acids. Here we showed that unbiased evolutionary methods followed by biased molecular dynamic simulations could achieve this goal and reveal critical elements of protein complexes. We applied the methodology to selected G-protein coupled receptors (GPCRs), known for their therapeutic properties. We used the structure-prior-assisted direct coupling analysis (SP-DCA) to predict the binding interfaces of A2aR/D2R, CB1R/D2R, A2aR/CB1R, 5HT2AR/D2R, and 5-HT2AR/mGluR2 receptor heterodimers, which all agreed with published data. In order to highlight details of the interactions, we performed molecular dynamic (MD) simulations using the newly developed AWSEM energy model. We found that these receptors interact primarily through critical residues at the C and N terminal domains and the third intracellular loop (ICL3). The MD simulations showed that these residues are energetically necessary for dimerization and revealed their native conformational state. We subsequently applied the methodology to the 5-HT2AR/5-HTR4R heterodimer, given its implication in drug addiction and neurodegenerative pathologies such as Alzheimer’s disease (AD). Further, the SP-DCA analysis showed that 5-HT2AR and 5-HTR4R heterodimerize through the C-terminal domain of 5-HT2AR and ICL3 of 5-HT4R. However, elucidating the details of GPCR interactions would accelerate the discovery of druggable sites and improve our knowledge of the etiology of common diseases, including AD.

Year:

2023

Year:

2023

Year:

2022

Collaborators (19)

Matthias Schmid

Professor / Director

University of Bonn

GERMANY
View details

Per Selnes

University of Oslo

NORWAY
View details

Eloy Rodriguez-Rodríguez

Instituto de Investigación Marqués de Valdecilla

SPAIN
View details

Anbupalam Thalamuthu

University of New South Wales

AUSTRALIA
View details

John Bertelson

Associate Professor

Texas Tech University Health Sciences Center

UNITED STATES
View details

Keeley Brookes

Senior Lecturer

University of Nottingham

UNITED KINGDOM
View details

Isabella Heuser

Senior Professor

Charité - Universitätsmedizin Berlin

GERMANY
View details

Elizabeth Fisher

University College London

UNITED KINGDOM
View details

Pierre Pericard

Co-head

Université de Lille

FRANCE
View details

Julien Chapuis

Université de Lille

FRANCE
View details

Mohsen Ghanbari

Associate Professor and Principal Investigator

Erasmus MC

NETHERLANDS
View details

Henrik Wilms

Texas Tech University Health Sciences Center

UNITED STATES
View details

Chloé Sarnowski

Assistant Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Seth Love

University of Bristol

UNITED KINGDOM
View details

Marcos R. Costa

Université de Lille

FRANCE
View details

Costas Anastasiou

Assistant Professor

-

GREECE
View details

Pilar Gómez-Garre

Instituto de Biomedicina de Sevilla

SPAIN
View details

Anita DeStefano

Professor

Boston University

UNITED STATES
View details

Jose Luis Royo

University of Malaga

SPAIN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.